Stock Events

Stock Events

RICI Enhanced Lead (ER) Index EUR Hedge ETC 

€31.55
47
-€0.24-0.75% Wednesday 15:30

Statistics

Day High
31.78
Day Low
31.71
52W High
35.81
52W Low
30.92
Volume
-
Avg. Volume
-
Mkt Cap
955.4M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Expense Ratio

1.20%
0%
1%+
The annual fee that you pay to the fund company for managing your investment. The lower the expense ratio, the better. This is not an investment recommendation.

Earnings

27AugExpected
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Q2 2026
-0.33
-0.03
0.26
0.55
Expected EPS
0.19599348484
Actual EPS
N/A

Financials

2.05%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
620.18MRevenue
12.73MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 0GZK.XETRA. It's not an investment recommendation.
Ageas SA/NV
8
AGS.BR
Sofina SA
8
SOF.BR
Proximus SA
7
PROX.BR
TotalEnergies
6
TTE.PA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Intuitive Surgical
ISRG
Mkt Cap138.95B
Intuitive Surgical, Inc. offers robotic-assisted surgical systems, indirectly competing with IBA by offering alternative cancer treatment and surgical solutions.
Medtronic
MDT
Mkt Cap117.85B
Medtronic plc manufactures and sells device-based medical therapies, including those for cancer, which can be seen as alternatives to radiation therapy.
GE Aerospace
GE
Mkt Cap326.07B
General Electric Company, through its healthcare division, provides medical imaging and other healthcare technologies that compete in the oncology market.
Koninklijke Philips N.V.
PHG
Mkt Cap24.12B
Koninklijke Philips N.V. offers various health technology products, including imaging systems that are used in diagnosing and treating cancer.
Siemens
SIEGY
Mkt Cap239.92B
Siemens Healthineers AG is a direct competitor in the medical imaging and radiation therapy equipment market, offering products that rival IBA's offerings.
Boston Scientific
BSX
Mkt Cap62.81B
Boston Scientific Corporation develops, manufactures, and markets medical devices that are used in a wide range of interventional medical specialties, including treatments that can compete with radiation therapy.
Abbvie
ABBV
Mkt Cap466.45B
AbbVie Inc. develops and markets pharmaceuticals that include oncology drugs, offering alternative therapeutic approaches to cancer treatment.
Thermo Fisher Scientific
TMO
Mkt Cap240.87B
Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics, indirectly competing by supporting alternative or complementary cancer treatment methodologies.

About

ION BEAM APPS SA ACT
Show more...
CEO
Olivier Legrain
Employees
2302
Country
Belgium
ISIN
DE000PZ9REL5
WKN
000PZ9REL

Listings

STU
DE
IOB.STU
MU
DE
0GZK.MU
STU
DE
0GZK.STU
MU
DE
IOB.MU

0 Comments

Share your thoughts

FAQ

What is RICI Enhanced Lead (ER) Index EUR Hedge ETC stock price today?▼
The current price of 0GZK.XETRA is €31.55 EUR — it has decreased by -0.75% in the past 24 hours. Watch RICI Enhanced Lead (ER) Index EUR Hedge ETC stock price performance more closely on the chart.
What is RICI Enhanced Lead (ER) Index EUR Hedge ETC stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XETRA Stock Exchange exchange RICI Enhanced Lead (ER) Index EUR Hedge ETC stocks are traded under the ticker 0GZK.XETRA.
Is RICI Enhanced Lead (ER) Index EUR Hedge ETC stock price growing?▼
0GZK.XETRA stock has risen by +0.14% compared to the previous week, the month change is a -0.6% fall, over the last year RICI Enhanced Lead (ER) Index EUR Hedge ETC has showed a -8.39% decrease.
What is RICI Enhanced Lead (ER) Index EUR Hedge ETC market cap?▼
Today RICI Enhanced Lead (ER) Index EUR Hedge ETC has the market capitalization of 955.4M
When is the next RICI Enhanced Lead (ER) Index EUR Hedge ETC earnings date?▼
RICI Enhanced Lead (ER) Index EUR Hedge ETC is going to release the next earnings report on March 25, 2027.
What is RICI Enhanced Lead (ER) Index EUR Hedge ETC revenue for the last year?▼
RICI Enhanced Lead (ER) Index EUR Hedge ETC revenue for the last year amounts to 620.18M EUR.
What is RICI Enhanced Lead (ER) Index EUR Hedge ETC net income for the last year?▼
0GZK.XETRA net income for the last year is 12.73M EUR.
How many employees does RICI Enhanced Lead (ER) Index EUR Hedge ETC have?▼
As of September 24, 2026, the company has 2,302 employees.
In which sector is RICI Enhanced Lead (ER) Index EUR Hedge ETC located?▼
RICI Enhanced Lead (ER) Index EUR Hedge ETC operates in the Health & Wellness sector.
When did RICI Enhanced Lead (ER) Index EUR Hedge ETC complete a stock split?▼
RICI Enhanced Lead (ER) Index EUR Hedge ETC has not had any recent stock splits.
Where is RICI Enhanced Lead (ER) Index EUR Hedge ETC headquartered?▼
RICI Enhanced Lead (ER) Index EUR Hedge ETC is headquartered in Louvain-la-Neuve, Belgium.